Gemigliptin: Newer Promising Gliptin for Type 2 Diabetes Mellitus

The dipeptidyl peptidase-4 (DPP-4) inhibitors have facilitated the management of type 2 diabetes mellitus (T2DM) owing to their superior efficacy and safety with low incidence of adverse effects. Gemigliptin is a new member of this family of drugs, and studies have revealed certain advantages of gem...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutch, Manish, Joshi, Abhay, Kumar, Sukriti, Agarwal, Avinash, Pahan, Rajendra Kumar, Razi, Syed Mohd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729681/
https://www.ncbi.nlm.nih.gov/pubmed/29285456
http://dx.doi.org/10.4103/ijem.IJEM_20_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729681/
https://www.ncbi.nlm.nih.gov/pubmed/29285456
http://dx.doi.org/10.4103/ijem.IJEM_20_17

Ejemplares similares